Listen as ACCEL Editor-in-Chief Dr. Spencer King interviews Dr. William W. O'Neill, professor at Henry Ford Hospital, regarding his latest trial, the WHIP COVID-19 (Will Hydroxychloroquine Impede or Prevent COVID-19) study. This study will enroll over 3,000 health care workers and first responders to test whether the anti-malarial drug hydroxychloroquine can prevent these workers from contracting COVID-19. Participants will be enrolled at Henry Ford Hospital Detroit.

References

• Henry Ford Health System to lead national study to determine drug's effectiveness in preventing COVID-19 (Henry Ford Health System website). April 2, 2020. Accessed April 14, 2020. Available at
  https://www.henryford.com/news/2020/04/hfhs-leads-national-study-to-determine-drugs-effectiveness-in-preventing-covid19

Clinical Topics: COVID-19 Hub, Novel Agents, Statins

Keywords: COVID-19, Coronavirus, Clinical Trial, Emergency Responders, Hydroxychloroquine, ACC COVID-19 Podcast

< Back to Listings